Modular Medical Announces Ongoing Progress to Obtain CE Mark
Key Highlights:Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for...
News
Olympia Pharmaceuticals Strengthens National Presence, Bringing New Licensing to Mississippi
The industry-leading 503B outsourcing facility grows its footprint to 49 states, offering expanded healthcare resources with a spotlight on MississippiORLANDO,...
VSee Awarded US Department of Health & Human Services FedRAMP High ATO
SAN JOSE, CALIFORNIA / ACCESS Newswire / October 28, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has...
Sevaro Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- CB Insights named Sevaro Health to its seventh annual Digital Health 50,...
Sharecare awarded three-year NCQA Accreditation for Wellness and Health Promotion
Accreditation for its lifestyle and disease management interventions complements Sharecare's existing three-year NCQA accreditations for Population Health Program and Case...
Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors...
Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience
ADELAIDE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service...
WellBridge Surgical Celebrates Dual Achievement: ACHC Accreditation and 2025 Best Places to Work Honor
ZIONSVILLE, IN / ACCESS Newswire / October 28, 2025 / WellBridge Surgical ("WellBridge") is delighted to announce two major milestones...
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company...
Little Leaves Behavioral Services Continues Strategic Expansion With Two New ABA Therapy Centers in Virginia
Chantilly and Tysons Corner sites expand access to early intervention services for young children with autismSILVER SPRING, Md., Oct. 28,...
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical...
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
Achieved key operational milestones establishing manufacturing capabilities to supply more than 2x the products required to achieve 2026 revenue targets...
Arcutis Outlines Strategy for Driving Sustainable Growth and Announces Third Quarter 2025 Financial Results
Q3 2025 net product revenue for ZORYVE® (roflumilast) was $99.2 million, a 122% increase compared to Q3 of 2024,...
Pure Harvest Corporate Group Signs Letter of Intent to Acquire Mixie IP Holdings and Mixie Labs
This Acquisition Advances PHCG’s Entry Into AI-Driven Video, 3D Data Visualization, and Immersive Media Technologies Powering Multiple IndustriesDENVER, Oct. 28,...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Working to Transform Underperforming Compounds into Next-Gen Cancer Therapies
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
More than 10,000 people receive verified World IDs at MEDIROM locations
“MEDIROM is a location partner for the World Network, co-founded by Sam Altman and Alex Blania, to promote domestic adoption...
CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies
Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing...
Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study
Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing Study Has...
Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025
Ness-Ziona, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at Women in Psychedelic Leadership Webinar
Vancouver, Canada, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...